Business Segments · R&D
Diagnostic Products — R&D
Abbott Diagnostic Products — R&D increased by 5.4% to $155.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.6%, from $151.00M to $155.00M. Over 3 years (FY 2022 to FY 2025), Diagnostic Products — R&D shows a downward trend with a -8.2% CAGR.
Analysis
StatementSegment
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2022
Last reportedQ1 2026
Rolls up toR&D
How to read this metric
Higher spending signals a commitment to long-term innovation, though it may temporarily compress current operating margins.
Detailed definition
Expenditures incurred to discover, develop, and improve diagnostic technologies, testing platforms, and clinical assays....
Peer comparison
Standard R&D expense metric used across the healthcare and life sciences industry.
Metric ID:
abt_segment_diagnostic_products_research_and_developmentHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $194.25M | $194.25M | $194.25M | $194.25M | $174.50M | $174.50M | $174.50M | $174.50M | $155.00M | $162.00M | $165.00M | $174.00M | $151.00M | $154.00M | $150.00M | $147.00M | $155.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -10.2% | +0.0% | +0.0% | +0.0% | -11.2% | +4.5% | +1.9% | +5.5% | -13.2% | +2.0% | -2.6% | -2.0% | +5.4% |
| YoY Change | — | — | — | — | -10.2% | -10.2% | -10.2% | -10.2% | -11.2% | -7.2% | -5.4% | -0.3% | -2.6% | -4.9% | -9.1% | -15.5% | +2.6% |
Range$147.00M – $194.25M
CAGR-5.5%
Avg YoY Growth-7.2%
Median YoY Growth-9.1%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Abbott's diagnostic products — r&d?
- Abbott (ABT) reported diagnostic products — r&d of $155.00M in Q1 2026.
- How has Abbott's diagnostic products — r&d changed year-over-year?
- Abbott's diagnostic products — r&d increased by 2.6% year-over-year, from $151.00M to $155.00M.
- What is the long-term trend for Abbott's diagnostic products — r&d?
- Over 3 years (2022 to 2025), Abbott's diagnostic products — r&d has grown at a -8.2% compound annual growth rate (CAGR), from $777.00M to $602.00M.
- What does diagnostic products — r&d mean?
- Spending on innovation and development of new diagnostic products.